|
1
|
Cersosimo RJ: Lung cancer: A review. Am J
Health Syst Pharm. 59:611–642. 2002.PubMed/NCBI
|
|
2
|
Parsons A, Daley A, Begh R and Aveyard P:
Influence of smoking cessation after diagnosis of early stage lung
cancer on prognosis: Systematic review of observational studies
with meta-analysis. BMJ. 340:b55692010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakashita S, Sakashita M and Sound Tsao M:
Genes and pathology of non-small cell lung carcinoma. Semin Oncol.
41:28–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar
|
|
5
|
Trédan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang B, Li KY, Chen HY, Pan SD, Jiang LC,
Wu YP and Liu SW: Spindle and kinetochore associated complex
subunit 1 regulates the proliferation of oral adenosquamous
carcinoma CAL-27 cells in vitro. Cancer Cell Int. 13:832013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qin X, Yuan B, Xu X, Huang H and Liu Y:
Effects of short interfering RNA-mediated gene silencing of SKA1 on
proliferation of hepatocellular carcinoma cells. Scand J
Gastroenterol. 48:1324–1332. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tian F, Xing X, Xu F, Cheng W, Zhang Z,
Gao J, Ge J and Xie H: Downregulation of SKA1 gene expression
inhibits cell growth in human bladder cancer. Cancer Biother
Radiopharm. 30:271–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun W, Yao L, Jiang B, Guo L and Wang Q:
Spindle and kinetochore-associated protein 1 is overexpressed in
gastric cancer and modulates cell growth. Mol Cell Biochem.
391:167–174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Xuan JW, Khatamianfar V, Valiyeva F,
Moussa M, Sadek A, Yang BB, Dong BJ, Huang YR and Gao WQ: SKA1
over-expression promotes centriole over-duplication, centrosome
amplification and prostate tumourigenesis. J Pathol. 234:178–189.
2014.PubMed/NCBI
|
|
12
|
Dong C, Wang XL and Ma BL: Expression of
spindle and kinetochore-associated protein 1 is associated with
poor prognosis in papillary thyroid carcinoma. Dis Markers.
2015:6165412015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi X, Chen X, Peng H, Song E, Zhang T,
Zhang J, Li J, Swa H, Li Y, Kim S, et al: Lentivirus-mediated
silencing of spindle and kinetochore-associated protein 1 inhibits
the proliferation and invasion of neuronal glioblastoma cells. Mol
Med Rep. 11:3533–3538. 2015.PubMed/NCBI
|
|
14
|
Gaitanos TN, Santamaria A, Jeyaprakash AA,
Wang B, Conti E and Nigg EA: Stable kinetochore-microtubule
interactions depend on the Ska complex and its new component
Ska3/C13Orf3. EMBO J. 28:1442–1452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Raaijmakers JA, Tanenbaum ME, Maia AF and
Medema RH: RAMA1 is a novel kinetochore protein involved in
kinetochore-microtubule attachment. J Cell Sci. 122:2436–2445.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Theis M, Slabicki M, Junqueira M,
Paszkowski-Rogacz M, Sontheimer J, Kittler R, Heninger AK, Glatter
T, Kruusmaa K, Poser I, et al: Comparative profiling identifies
C13orf3 as a component of the Ska complex required for mammalian
cell division. EMBO J. 28:1453–1465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanisch A, Silljé HH and Nigg EA: Timely
anaphase onset requires a novel spindle and kinetochore complex
comprising Ska1 and Ska2. EMBO J. 25:5504–5515. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang M, Liu ZM, Li XC, Yao YT and Yin ZX:
Activation of ERK1/2 and Akt is associated with cisplatin
resistance in human lung cancer cells. J Chemother. 25:162–169.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen TJ, Zhou YF, Ning JJ, Yang T, Ren H,
Li Y, Zhang S and Chen MW: NBM-T-BMX-OS01, an osthole derivative,
sensitizes human lung cancer A549 cells to cisplatin through
AMPK-dependent inhibition of ERK and Akt Pathway. Cell Physiol
Biochem. 36:893–906. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stinchcombe TE and Johnson GL: MEK
inhibition in non-small cell lung cancer. Lung Cancer. 86:121–125.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yip PY: Phosphatidylinositol
3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR)
signaling pathway in non-small cell lung cancer. Transl Lung Cancer
Res. 4:165–176. 2015.PubMed/NCBI
|
